Bioxytran, Inc. (BIXT)

USD 0.18

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 8285.00 3644.00 - - - -
Gross Profit -8285.00 -3644.00 - - - -
Operating Expenses 3.82 Million 2.13 Million 4.21 Million 1.26 Million 1.63 Million 214.71 Thousand
Selling, General and Administrative Expenses 2.67 Million 1.15 Million 2.2 Million 724.18 Thousand 1.63 Million 214.71 Thousand
Research and Development Expenses 1.14 Million 977.76 Thousand 2.01 Million 544.51 Thousand - -
Other Expenses - 3644.00 582.86 Thousand 247.86 Million 1.12 Billion -
Cost and Expenses 3.82 Million 2.13 Million 4.21 Million 1.26 Million 1.63 Million 214.71 Thousand
Operating Income -3.82 Million -2.13 Million -4.21 Million -1.26 Million -1.63 Million -214.71 Thousand
Interest Expense 541.82 Thousand 519.54 Thousand 313.6 Thousand 1.27 Million 227 Thousand 8375.00
Income Tax Expense - -193.37 Thousand -182.68 Thousand 1.21 Million 227 Thousand 400.00
Earnings before Tax -4.37 Million -2.65 Million -4.52 Million -2.54 Million -1.85 Million -296.01 Thousand
Net Income -4.28 Million -2.46 Million -4.34 Million -3.75 Million -2.08 Million -296.41 Thousand
Earnings Per Share Basic -0.03 -0.02 -0.04 -0.04 -0.02 -0.00
Earnings Per Share Diluted -0.03 -0.02 -0.04 -0.04 -0.02 -0.00
Weighted Average Shares Outstanding 134.22 Million 115.13 Million 106.25 Million 93.96 Million 85.59 Million 85.1 Million
Weighted Average Shares Outstanding (Diluted) 134.22 Million 115.13 Million 106.25 Million 93.96 Million 85.59 Million 85.1 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -3.82 Million -2.13 Million -4.21 Million -1.26 Million -1.63 Million -
Earnings Before Tax Margin - - - - - -

Income Statement Charts